Large-scale testing (Phase 3)Study completedNCT02714322What this trial is testingMYL-1401A Efficacy and Safety Comparability Study to Humira®Who this might be right forPsoriasisArthritis, Psoriatic Mylan Inc. 294
Testing effectiveness (Phase 2)Study completedNCT00236119What this trial is testingStudy of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe PsoriasisWho this might be right forPsoriasis Cephalon 46
Not applicableStudy completedNCT00799877What this trial is testingChronic Plaque Psoriasis (Ps) RegistryWho this might be right forChronic Plaque Psoriasis AbbVie 6,065
Post-approval studies (Phase 4)Study completedNCT03718299What this trial is testingA Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With PsoriasisWho this might be right forPsoriasis Sun Pharmaceutical Industries Limited 55
Post-approval studies (Phase 4)UnknownNCT01237262What this trial is testingEvaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors TherapyWho this might be right forModerate to Severe Psoriasis.Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern. University of Padova 20
Large-scale testing (Phase 3)Study completedNCT01468233What this trial is testingEfficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis SuppurativaWho this might be right forHidradenitis Suppurativa (HS) AbbVie (prior sponsor, Abbott) 326
Testing effectiveness (Phase 2)Study completedNCT04080206What this trial is testingA Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque PsoriasisWho this might be right forPlaque Psoriasis Therapeutics, Inc. 55
Not applicableStudy completedNCT01401452What this trial is testingEffectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbiditiesWho this might be right forModerate to Severe Plaque Psoriasis AbbVie (prior sponsor, Abbott) 246
Not applicableStudy completedNCT05787236What this trial is testingModerate-to-severe Plaque Psoriasis Patients Response to Secukinumab Treatment in Real-world SettingWho this might be right forModerate-to-severe Plaque Psoriasis Novartis Pharmaceuticals 79
Large-scale testing (Phase 3)Ended earlyNCT02527421What this trial is testingDFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Primus Pharmaceuticals 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT07090330What this trial is testingORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Oruka Therapeutics, Inc. 80
Testing effectiveness (Phase 2)Study completedNCT03384745What this trial is testingA Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe PsoriasisWho this might be right forPsoriasis Bond Avillion 2 Development LP 313
Not applicableStudy completedNCT01126619What this trial is testingEffectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe PsoriasisWho this might be right forPsoriasis Abbott 103
Testing effectiveness (Phase 2)Study completedNCT01988103What this trial is testingEfficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type PsoriasisWho this might be right forPsoriasisPsoriatic ArthritisPsoriasis Arthropatica Amgen 254
Post-approval studies (Phase 4)Study completedNCT03988439What this trial is testingA Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque PsoriasisWho this might be right forPsoriasis Bausch Health Americas, Inc. 16
Large-scale testing (Phase 3)Study completedNCT01276639What this trial is testingA One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Pfizer 901
Testing effectiveness (Phase 2)Study completedNCT02413229What this trial is testingDouble Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical StudyWho this might be right forPlaque Psoriasis Sun Pharmaceutical Industries, Inc. 151
Large-scale testing (Phase 3)Study completedNCT03210259What this trial is testingThe VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque PsoriasisWho this might be right forPsoriasis Boehringer Ingelheim 259
Large-scale testing (Phase 3)Study completedNCT00307437What this trial is testingThe Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe PsoriasisWho this might be right forPsoriasis Centocor Research & Development, Inc. 1,230
Not applicableLooking for participantsNCT03392337What this trial is testingAn Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis PatientsWho this might be right forPsoriasis Psoriasis Treatment Center of Central New Jersey 30